In this insightful chat, Professor Nikolai Slavov, an expert in bioengineering at Northeastern University, delves into the groundbreaking world of single-cell proteomics. He discusses the central dogma of biology, emphasizing the importance of proteins in drug development. Professor Slavov shares the challenges of measuring complex protein interactions and the underfunding issues plaguing proteomics research. The conversation highlights advanced technologies like mass spectrometry, revealing their potential to transform diagnostics and biopharma R&D.